These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 22569294

  • 1. Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats.
    Kimura K, Ohkita M, Koyama M, Matsumura Y.
    Life Sci; 2012 Oct 15; 91(13-14):644-50. PubMed ID: 22569294
    [Abstract] [Full Text] [Related]

  • 2. Involvement of the endothelin ET(B) receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension.
    Kawanishi H, Hasegawa Y, Nakano D, Ohkita M, Takaoka M, Ohno Y, Matsumura Y.
    Clin Exp Pharmacol Physiol; 2007 Apr 15; 34(4):280-5. PubMed ID: 17324138
    [Abstract] [Full Text] [Related]

  • 3. Gene transfer of human guanosine 5'-triphosphate cyclohydrolase I restores vascular tetrahydrobiopterin level and endothelial function in low renin hypertension.
    Zheng JS, Yang XQ, Lookingland KJ, Fink GD, Hesslinger C, Kapatos G, Kovesdi I, Chen AF.
    Circulation; 2003 Sep 09; 108(10):1238-45. PubMed ID: 12925450
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Different contributions of endothelin-A and endothelin-B receptors in the pathogenesis of deoxycorticosterone acetate-salt-induced hypertension in rats.
    Matsumura Y, Hashimoto N, Taira S, Kuro T, Kitano R, Ohkita M, Opgenorth TJ, Takaoka M.
    Hypertension; 1999 Feb 09; 33(2):759-65. PubMed ID: 10024341
    [Abstract] [Full Text] [Related]

  • 6. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T, Miyauchi T, Sakai S, Takanashi M, Irukayama-Tomobe Y, Yamaguchi I.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1481-8. PubMed ID: 15093887
    [Abstract] [Full Text] [Related]

  • 7. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
    Lee TM, Chung TH, Lin SZ, Chang NC.
    J Hypertens; 2014 Apr 21; 32(4):795-805. PubMed ID: 24463935
    [Abstract] [Full Text] [Related]

  • 8. NADPH oxidase-derived superoxide augments endothelin-1-induced venoconstriction in mineralocorticoid hypertension.
    Li L, Watts SW, Banes AK, Galligan JJ, Fink GD, Chen AF.
    Hypertension; 2003 Sep 21; 42(3):316-21. PubMed ID: 12885792
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Activation of the ET-1/ETA pathway contributes to erectile dysfunction associated with mineralocorticoid hypertension.
    Carneiro FS, Nunes KP, Giachini FR, Lima VV, Carneiro ZN, Nogueira EF, Leite R, Ergul A, Rainey WE, Clinton Webb R, Tostes RC.
    J Sex Med; 2008 Dec 21; 5(12):2793-807. PubMed ID: 18823320
    [Abstract] [Full Text] [Related]

  • 11. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.
    Zhou MS, Schulman IH, Raij L.
    J Hypertens; 2010 Mar 21; 28(3):527-35. PubMed ID: 19898250
    [Abstract] [Full Text] [Related]

  • 12. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS, Turgeon A, Schiffrin EL.
    Am J Hypertens; 1998 May 21; 11(5):554-62. PubMed ID: 9633791
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Involvement of endothelin-1 in deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy.
    Matsumura Y, Fujita K, Miyazaki Y, Takaoka M, Morimoto S.
    J Cardiovasc Pharmacol; 1995 May 21; 26 Suppl 3():S456-8. PubMed ID: 8587444
    [Abstract] [Full Text] [Related]

  • 15. Coronary vascular reactivity is improved by endothelin A receptor blockade in DOCA-salt hypertensive rats.
    Giulumian AD, Pollock DM, Clarke N, Fuchs LC.
    Am J Physiol; 1998 Jun 21; 274(6):R1613-8. PubMed ID: 9608015
    [Abstract] [Full Text] [Related]

  • 16. Endothelin-1 contributes to the sexual differences in renal damage in DOCA-salt rats.
    Montezano AC, Callera GE, Mota AL, Fortes ZB, Nigro D, Carvalho MH, Zorn TM, Tostes RC.
    Peptides; 2005 Aug 21; 26(8):1454-62. PubMed ID: 16042985
    [Abstract] [Full Text] [Related]

  • 17. Effect of an ET(B)-selective and a mixed ET(A/B) endothelin receptor antagonist on venomotor tone in deoxycorticosterone-salt hypertension.
    Johnson RJ, Galligan JJ, Fink GD.
    J Hypertens; 2001 Mar 21; 19(3):431-40. PubMed ID: 11288813
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ETA receptor blockade attenuates the hypertension but not renal dysfunction in DOCA-salt rats.
    Allcock GH, Venema RC, Pollock DM.
    Am J Physiol; 1998 Jul 21; 275(1):R245-52. PubMed ID: 9688985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.